{"authors": ["James Gallagher", "www.facebook.com"], "date_download": "2025-05-19 15:30:46", "date_modify": "2025-05-19 15:30:46", "date_publish": "2015-02-05 03:53:00", "description": "Far more money needs to be pumped into global drug research to tackle the looming threat of antimicrobial resistance, a report says.", "filename": "news_health-31128971_1747668646.html", "image_url": "https://ichef.bbci.co.uk/ace/branded_news/1200/mcs/media/images/80787000/jpg/_80787488_c0214478-mycobacterium_tuberculosis-spl.jpg", "language": "en", "localpath": "C:\\Users\\vopha/news-please-repo//data/2025/05/19/bbc.com/news_health-31128971_1747668646.html", "title": "Call to boost antibiotics funding to tackle 'looming crisis'", "title_page": "Call to boost antibiotics funding to tackle 'looming crisis' - BBC News", "title_rss": "NULL", "source_domain": "bbc.com", "maintext": "Far more money needs to be pumped into global drug research to tackle the looming crisis of antimicrobial resistance, a report says.\nThe economist Jim O'Neill has been appointed by UK Prime Minister David Cameron to head a review on the issue.\nIn his first recommendations, external, he says the gap between spending on cancer and antibiotic research needs to be closed.\nHe has already warned that drug-resistant infections will kill an extra 10 million people a year by 2050.\nThat is more than currently die from cancer and Mr O'Neill says the global cost will spiral to $100tn (Â£63tn).\nHe points to the US where $26bn was spent on cancer research between 2010 and 2014.\nIn that period $14bn went to HIV, yet just $1.7bn was spend on antimicrobial resistance.\nHe has published a series of recommendations aimed at tackling resistance.\nThey are:", "url": "https://www.bbc.com/news/health-31128971"}